Investor's Calendar

December 2027

Mon Tue Wed Thu Fri Sat Sun
29
30
1
2
3
4
5
 
 
 
 
 
 
 
6
7
8
9
10
11
12
 
 
 
 
 
 
 
13
14
15
16
17
18
19
 
 
 
 
 
 
 
20
21
22
23
24
25
26
 
 
 
 
 
 
 
27
28
29
30
31
1
2
 
 
 
 
 
 
 

Next Events

Last News

First nine months of 2025 results press release
ROVI ACHIEVED OPERATING REVENUE OF 525.1 MILLION EUROS AND INCREASED ITS GROSS MARGIN BY 3.5 PERCENTAGE POINTS
4 min
06 Nov, 2025
ROVI announces a collaboration with Roche for the manufacture of a new medicine in...
The Swiss company has placed its confidence in ROVI for the manufacture of this product for its global launch
3 min
21 Oct, 2025
ROVI announces the acquisition of an injectable drug product manufacturing site in...
1 min
29 Sep, 2025

See more

Financial and Business Information

Information for investors

Marta Campos

Marta Campos

Head of Investor Relations

mcampos@rovi.es

Antonio Marquina

Antonio Marquina

Investor Relations

amarquina@rovi.es

buzón general Rovi

General Email

ir@rovi.es